We report our experience with 2 infants with in utero HIV-1 infection who began very early combination antiretroviral therapy within 4 hours of birth. Further neonatal studies of antiretroviral pharmacokinetics (PKs), safety, efficacy and treatment strategies are critically needed for the development of more potent regimens for use in HIV-infected infants.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/INF.0000000000001353 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!